GENova Biotherapeutics inks deal with Beckpharma

GENova Biotherapeutics Inc (GENova), a biotechnology company that develops novel therapeutic proteins that disrupt the advance of life-threatening cancers, has signed a collaboration deal with Beckpharma Ltd (Beckpharma) - a pharmaceutical development company also involved in cancer treatments.

The two companies are joining forces in their mutual mission to identify, acquire, and out-license promising cancer drugs in an effort that will not only save millions on GENova's R D budget, but at the same time will significant increase GENova's distribution, the deal with Beckpharma is the latest deal in a string of deals that GENova has recently done in a continued effort to increase its IP portfolio and increase its distribution network.

Comments

Popular posts from this blog

GOP Senator says it's hard to fund $14 billion children's health care program — then advocates for $1 trillion tax cut

Trump wants more mental health care; Alabama says it's trying